NYSE · CC

The Chemours Company

$17.22 -$0.25 (-1.43%) 1D After hours

Key Metrics

$2.59B
Market cap
P/E · TTM
$5.82B
Revenue · TTM
−$411.00M
Net income
EPS · TTM $-2.74
Dividend yield 2.1%
Free cash flow $154.00M
Beta · 1Y 1.69
EBITDA · TTM −$38.00M
Gross margin 15.1%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 20
    From its May 5 high, the share price fell 39%.

    Peak close $27.94 on May 5; trough close $17.18 on Jul 20. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -39%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 6
    The stock moved -15.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 6
  • Feb 20
    The stock moved -16.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 20

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.59B
Enterprise value$6.16B
Shares outstanding150.4M
52-wk range$10.44 – $28.67
Avg volume · 20D1.9M
Net cash −$3.57B
Book value / share$1.43
IndustryChemicals & Allied Products
ExchangeNYSE
About The Chemours Company
IPO dateJun 19, 2015
Employees5700

The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, paints and coatings, plastics, transportation, semiconductor, and others.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.44
P/FCF16.81
EV/EBITDA
EV/Sales1.06
Graham №

Profitability

Gross 15.1%
Operating -6.3%
Net -7.1%
FCF 2.6%
ROE / ROIC -100.4% · -12.7%

Financial Health

Current ratio1.82
Quick ratio0.87
Debt / equity19.24
Debt / EBITDA -108.87
Net cash −$3.57B
Working capital$1.32B

Cash Flow · TTM

Operating CF $332.00M
Capex −$178.00M
Free cash flow $154.00M
Buybacks
Dividends paid $54.00M
Shareholder yield 2.1%

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

1.3
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings